Susquehanna International Group’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$152K Sell
40,789
-59,092
-59% -$408K ﹤0.01% 11984
2025
Q4
$817K Buy
99,881
+61,428
+160% +$454K ﹤0.01% 7626
2025
Q3
$283K Sell
38,453
-17,224
-31% -$130K ﹤0.01% 10258
2025
Q2
$452K Buy
55,677
+18,421
+49% +$124K ﹤0.01% 9413
2025
Q1
$262K Buy
37,256
+18,274
+96% +$114K ﹤0.01% 10367
2024
Q4
$141K Buy
18,982
+7,951
+72% +$50.8K ﹤0.01% 11066
2024
Q3
$54.4K Sell
11,031
-6,813
-38% -$35.6K ﹤0.01% 11349
2024
Q2
$91.5K Sell
17,844
-149,251
-89% -$884K ﹤0.01% 11084
2024
Q1
$887K Sell
167,095
-58,872
-26% -$421K ﹤0.01% 7182
2023
Q4
$1.4M Sell
225,967
-109,197
-33% -$758K ﹤0.01% 6161
2023
Q3
$2.53M Buy
335,164
+8,149
+2% +$74.5K ﹤0.01% 4687
2023
Q2
$3.16M Buy
327,015
+274,103
+518% +$1.67M 0.01% 4272
2023
Q1
$200K Buy
52,912
+34,585
+189% +$193K ﹤0.01% 10596
2022
Q4
$119K Buy
+18,327
New +$151K ﹤0.01% 10777
2022
Q2
Sell
-10,092
Closed -$117K 13628
2022
Q1
$117K Buy
+10,092
New +$112K ﹤0.01% 11785
2021
Q3
Sell
-23,405
Closed -$263K 13334
2021
Q2
$263K Buy
+23,405
New +$270K ﹤0.01% 11051
2019
Q4
Sell
-17,288
Closed -$188K 10319
2019
Q3
$188K Buy
17,288
+5,928
+52% +$64.5K ﹤0.01% 9156
2019
Q2
$106K Buy
+11,360
New +$115K ﹤0.01% 9579
2018
Q3
Sell
-11,519
Closed -$172K 10132
2018
Q2
$172K Sell
11,519
-16,330
-59% -$227K ﹤0.01% 8744
2018
Q1
$363K Buy
+27,849
New +$366K ﹤0.01% 7282
2017
Q1
Sell
-39,954
Closed -$551K 9647
2016
Q4
$551K Buy
+39,954
New +$554K ﹤0.01% 6780
2015
Q1
Sell
-21,143
Closed -$292K 9734
2014
Q4
$292K Buy
+21,143
New +$273K ﹤0.01% 8179
2014
Q3
Sell
-11,755
Closed -$147K 9753
2014
Q2
$147K Buy
+11,755
New +$138K ﹤0.01% 9253
2014
Q1
Sell
-13,614
Closed -$149K 9246
2013
Q4
$165K Sell
13,614
-3,436
-20% -$41K ﹤0.01% 8396
2013
Q3
$208K Buy
+17,050
New +$238K ﹤0.01% 7723

Other funds holding LFCR